Finally, VAG539 injections in K/BxN‐treated Il‐22 deficient mice did not improve arthritis symptoms (Figure S3), demonstrating that IL‐22 production is required downstream of AHR activation to promote protective effects. The gene discussed is IL22; the disease is arthritic joint disease.